Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and tolerability of aripiprazole in the treatment of acutely
relapsed patients with diagnoses of schizophrenia or schizoaffective disorder with
risperidone as an active control.